Steven G. Deeks

Steven G. Deeks, MD, is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and a faculty member in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital. He is an internationally recognized expert in HIV pathogenesis, treatment, and cure research, with a recent focus on Long COVID pathogenesis. Dr. Deeks leads the NIH-funded Delaney AIDS Research Enterprise (DARE) and established the Long-term Impact of Infection with Novel Coronavirus (LIINC) cohort.

Education:

• University of California, San Francisco: Residency, School of Medicine
• University of California, San Francisco: MD, Medicine (1990)

Research Interests: Dr. Deeks' work spans HIV persistence, inflammation, therapeutic interventions (including immunotherapy and latency reversal), and Long COVID biomarkers. His research integrates virology, immunology, and clinical trials to address viral reservoirs, immune dysregulation, and treatment strategies.

Publications: With over 700 articles, his recent works emphasize HIV cure strategies (e.g., mRNA delivery, latency reversal) and Long COVID mechanisms (e.g., immune/metabolic dysfunction, viral persistence). Trends include biomarker discovery, combinatorial therapies, and transcriptomic profiling.

Awards:

• Lifetime Achievement in Mentoring Award, UCSF (2022)
• Member, American Society for Clinical Investigation (ASCI)
• Member, Association of American Physicians (AAP)
• Consistently ranked among the world's most cited scientists

Grants and Leadership: As principal investigator, he oversees multimillion-dollar NIH grants for HIV cure research (e.g., DARE collaboratory) and Long COVID studies. He maintains a primary care HIV clinic and mentors emerging scientists.

Teams: Leads interdisciplinary teams at UCSF and Zuckerberg Hospital focused on HIV/Long COVID pathogenesis, clinical trials, and translational research.